#8,294 by institutional money · Stock
Processa Pharmaceuticals, Inc. (PCSA)
Institutional ownership from Q3 2026 Form 13F filings
$1.69
−0.59% today
Market closed. Prices as of Nov 20, 8:11 AM ET
- 13F holders
- 18 (+6)
- Held by 13F filers, live
- $6.2M
- Shares held
- 3,694,225
- Share of stock outstanding
- 100.0%
- Net buying in Q3 2026
- +$5.8M
- New positions / sold out
- 7 / 3
Reported 13F holdings exceed the shares outstanding. This happens when shares on loan are reported by both the lender and the borrower's custodian, and when several advisers report the same shares.
Largest holders
18 investors| Investor | Shares | Value, live | % of their portfolio | vs Q2 2026 |
|---|---|---|---|---|
| Adage Capital Partners GP, L.l.c. | 3,275,493 | $5.5M | <0.1% | New |
| Soleus Capital Management, L.P. | 160,943 | $272K | <0.1% | New |
| Connective Capital Management, LLC | 85,274 | $144K | 0.13% | Unchanged |
| Citadel Advisors LLC Ken Griffin | 58,629 | $99K | <0.1% | Added +175% |
| Geode Capital Management, LLC | 31,252 | $53K | <0.1% | Added +41% |
| Seven Fleet Capital Management LP | 18,300 | $31K | <0.1% | New |
| Janus Henderson Group Ltd. | 18,016 | $30K | <0.1% | First filing |
| Jane Street Group, LLC | 13,571 | $23K | <0.1% | Added +2% |
| Vanguard Capital Management LLC | 12,729 | $22K | <0.1% | Unchanged |
| Vanguard Fiduciary Trust Co | 10,857 | $18K | <0.1% | Unchanged |
| UBS Group AG | 6,774 | $11K | <0.1% | Reduced −13% |
| Millennium Management LLC Israel Englander | 1,875 | $3K | <0.1% | New |
| Tower Research Capital LLC (TRC) | 419 | $708 | <0.1% | Reduced −83% |
| Robinhood Markets, Inc. | 59 | $100 | <0.1% | First filing |
| JPMORGAN Chase & Co | 18 | $30 | <0.1% | New |
| Jones Financial Companies Lllp | 7 | $12 | <0.1% | Unchanged |
| FMR LLC | 6 | $10 | <0.1% | New |
| Barclays Plc | 3 | $5 | <0.1% | New |